To test the potential causal relationship between FIRΔexon2 and BRG1 and invasive gastric cancer, an introduction of FIRΔexon2 by CRISPR editing in FIR+/− mouse or PDX (Patient Derived Xenograft) could be expected to induce an invasive tumor in future experiment. The gene discussed is SMARCA4; the disease is neoplasm.